contains the active ingredient valganciclovir
CONSUMER MEDICINE INFORMATION
What is in this leaflet
This leaflet answers some common questions about VALGANCICLOVIR MYLAN tablets.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the risks of you taking
VALGANCICLOVIR MYLAN against the benefits expected for you.
If you have any concerns about taking this medicine, talk to your doctor or pharmacist.
Keep this leaflet with your medicine.
You may need to read it again.
What VALGANCICLOVIR MYLAN is used for
VALGANCICLOVIR MYLAN contains the active ingredient valganciclovir. In the body valganciclovir
rapidly changes to ganciclovir.
VALGANCICLOVIR MYLAN belongs to a class of medicines used to prevent the growth of
VALGANCICLOVIR MYLAN acts against a virus called cytomegalovirus or CMV (a type of
herpes virus). It prevents this virus from growing and multiplying in the body. CMV
causes infections, mainly in people with poor immunity. Poor immunity can be caused
by HIV/AIDS or by medications taken after an organ transplant.
VALGANCICLOVIR MYLAN is used to treat CMV eye infections (known as CMV retinitis)
in AIDS patients, which, if left untreated can cause blindness. It is not a cure for
CMV eye infections.
VALGANCICLOVIR MYLAN is not effective against any underlying HIV infection.
VALGANCICLOVIR MYLAN is also used to prevent CMV infection in patients following organ
Your doctor, however, may have prescribed VALGANCICLOVIR MYLAN for another purpose.
Ask your doctor if you have any questions about why VALGANCICLOVIR MYLAN has been
prescribed for you.
VALGANCICLOVIR MYLAN is not addictive.
This medicine is available only with a doctor's prescription.
Before you take VALGANCICLOVIR MYLAN
Animal and other laboratory studies have shown VALGANCICLOVIR MYLAN causes infertility,
birth defects and cancer. It is possible that these effects may also occur in humans.
When you must not take it
Do not take VALGANCICLOVIR MYLAN if you have had an allergy to VALGANCICLOVIR MYLAN,
ganciclovir, valaciclovir or aciclovir or any ingredients at the end of this leaflet:
Some of the symptoms of an allergic reaction may include:
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body
rash, itching or hives on the skin
Do not take VALGANCICLOVIR MYLAN if you have very low blood counts for platelets (which
help clotting), neutrophils (a type of white blood cell which defends against infection)
or low haemoglobin (oxygen carrying substance in the blood).
Do not take VALGANCICLOVIR MYLAN after the expiry date (EXP) printed on the pack has
passed or if the packaging is torn or shows signs of tampering.
If it has expired or is damaged, return it to your pharmacist for disposal.
If you are not sure whether you should start taking VALGANCICLOVIR MYLAN, talk to
Use in children
There is limited information on the safety and effectiveness of the use of VALGANCICLOVIR
MYLAN in children. Your doctor will advise you whether VALGANCICLOVIR MYLAN is suitable
for your child.
Before you start to take it
Tell your doctor if:
you are allergic to any other medicines, foods, dyes or preservatives, especially
any medicine which you have taken previously to treat your current condition.you have,
any other health problems, especially the following:
you have a history of low blood counts for platelets (thrombocytopenia), neutrophils
(neutropenia) or anaemia
you have, or previously have had, poor kidney function.
you are pregnant or intend to become pregnant.
VALGANCICLOVIR MYLAN is not recommended for use during pregnancy. VALGANCICLOVIR MYLAN
may affect your developing baby if you take it during pregnancy. Your doctor will
discuss the risks and benefits of using VALGANCICLOVIR MYLAN if you are pregnant.
you are breast-feeding or intend to breast-feed.
It is not known whether VALGANCICLOVIR MYLAN passes into breast milk. Breast-feeding
is not recommended during therapy with VALGANCICLOVIR MYLAN.
you are a woman who could become pregnant and you are not using contraception
you must use a reliable form of contraception during VALGANCICLOVIR MYLAN therapy,
and for at least 30 days after stopping VALGANCICLOVIR MYLAN, unless you are not sexually
you are a sexually active man
you should use condoms during and for at least 90 days following treatment with VALGANCICLOVIR
MYLAN unless it is certain that your female partner is not at risk of pregnancy.
If you have not told your doctor about any of the above, tell him/her before you start
taking VALGANCICLOVIR MYLAN.
Taking other medicines
Tell your doctor or pharmacist if you are taking any other medicines, including any
that you get without a prescription from a pharmacy, supermarket or health food shop.
Some medicines and VALGANCICLOVIR MYLAN may interfere with each other. These medicines
imipenem/cilastatin (Primaxin®), a combination of medicines used to treat some infections
probenecid (e.g. Benemid®), a medicine used to treat gout
zidovudine (AZT, Retrovir®, Combivir), didanosine (ddl or Videx®), stavudine, also known as D4T, other medicines used to treat HIV infection
medicines for the treatment of cancer such as vincristine, adriamycin, hydroxyurea
mycophenolate mofetil (CellCept®), and other medicines used to prevent organ rejection after a transplant e.g. ciclosporin,
anti-infective agents such as trimethoprim / sulphonamides dapsone, pentamidine, flucytosine,
pegylated interferons plus ribavirin and amphotericin B
These medicines may be affected by VALGANCICLOVIR MYLAN, or may affect how well it
works. You may need different amounts of your medicine, or you may need to take different
Your doctor or pharmacist have more information on medicines to be careful with or
avoid while taking VALGANCICLOVIR MYLAN.
Ask your doctor or pharmacist if you are not sure about this list of medicines.
How to take VALGANCICLOVIR MYLAN
Follow all directions given to you by your doctor or pharmacist carefully.
They may differ from the information contained in this leaflet.
If you do not understand the instructions on the bottle, ask your doctor or pharmacist
How much to take
Take VALGANCICLOVIR MYLAN exactly as your doctor has prescribed.
Your doctor will tell you how many VALGANCICLOVIR MYLAN tablets to take each day.
Treatment of CMV Retinitis in AIDS
Induction Treatment for adults (for active CMV retinitis)
The usual dose is 900 mg (two 450 mg tablets) twice daily with food for 21 days.
Maintenance Treatment for adults (after induction treatment or for inactive CMV retinitis)
The usual dose is 900 mg (two 450 mg tablets) once daily with food.
Prevention of CMV Disease in Transplantation for adults
The usual dose is 900 mg (two 450 mg tablets) once daily with food, starting within
10 days post transplantation until 100 days post transplantation.
If you have received a kidney transplant, the same daily dose is required until 200
days post transplantation.
Your dose may have to be reduced or stopped if you have or develop low blood counts,
have kidney disease, or if you are older than 65 years.
Prevention of CMV Disease in Transplantation for children
Your doctor will let you know how many VALGANCICLOVIR MYLAN tablets you should give
your child each day.
How to take it
Swallow tablets whole with a glass of water. VALGANCICLOVIR MYLAN must be taken with
When to take it
Take VALGANCICLOVIR MYLAN during or immediately after a meal.
If you take VALGANCICLOVIR MYLAN on an empty stomach, it may not work as well.
Take VALGANCICLOVIR MYLAN at about the same time each day.
Taking your medicine at the same time each day will have the best effect. It will
also help you remember when to take VALGANCICLOVIR MYLAN.
How long to take it for
Continue taking VALGANCICLOVIR MYLAN until your doctor tells you to stop.
If you forget to take it
If it is almost time for your next dose, skip the dose you missed and take your next
dose when you are meant to.
Otherwise, take it as soon as you remember and then go back to taking it as you would
Do not take a double dose to make up for the dose you missed.
If you are not sure what to do, ask your doctor or pharmacist.
If you have trouble remembering your dose, ask your pharmacist for some hints.
If you take too much (overdose)
Immediately telephone your doctor, or the Poisons Information Centre (telephone 13
11 26) for advice, or go to Accident and Emergency at your nearest hospital, if you
think that you or anyone else may have taken too much VALGANCICLOVIR MYLAN. Do this
even if there are no signs of discomfort or poisoning.
You may need urgent medical attention.
Keep telephone numbers for these places handy.
If you are not sure what to do, contact your doctor or pharmacist.
While you are taking VALGANCICLOVIR MYLAN
Things you must do
Tell all doctors, dentists and pharmacists who treat you that you are taking VALGANCICLOVIR
See your doctor regularly so that your CMV disease, blood cell counts and any other
potential side effects may be monitored carefully.
If blood cell counts are low then this may reduce your ability to fight infection,
or for your blood to clot efficiently. If left undetected these effects on blood cells
may contribute to death or serious illness.
If you have a CMV eye infection, you must also see your doctor regularly to monitor
the condition of your retina (part of the eye).
If you become pregnant while taking VALGANCICLOVIR MYLAN, tell your doctor immediately.
Condoms should be used by sexually active men while taking VALGANCICLOVIR MYLAN and
for 90 days after stopping treatment.
Women who are of childbearing potential should use contraception during and for at
least 30 days after stopping VALGANCICLOVIR MYLAN.
Tell your doctor if for any reason you have not taken your medicine exactly as prescribed.
Otherwise, your doctor may think that it was not effective and change your treatment
Keep all of your doctor's appointments so that your progress can be checked.
Things you must not do
Do not take VALGANCICLOVIR MYLAN to treat any other complaints unless your doctor
tells you to.
Do not give VALGANCICLOVIR MYLAN to anyone else even if they have the same condition
Do not stop taking VALGANCICLOVIR MYLAN or change the dosage without first checking
with your doctor.
Do not let yourself run out of medicine over the weekend or on holidays.
Do not take any other medicines whether they require a prescription or not without
first telling your doctor or consulting a pharmacist.
Be careful when handling VALGANCICLOVIR MYLAN tablets. Do not break or crush them.
If you accidentally touch broken or crushed tablets, wash your hands thoroughly with
soap and water. If any powder from the tablet gets in your eyes, rinse your eyes thoroughly
Be careful driving or operating machinery until you know how VALGANCICLOVIR MYLAN
VALGANCICLOVIR MYLAN may cause drowsiness, dizziness, confusion or seizures (fits)
in some people and therefore may affect alertness. If you have any of these symptoms,
do not drive or operate machinery or do anything else that could be dangerous.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you
are taking VALGANCICLOVIR MYLAN.
VALGANCICLOVIR MYLAN helps most people with CMV infections but it may have unwanted
side effects in a few people.
All medicines can have side effects. Sometimes they are serious, most of the time
they are not. Your doctor has weighed the risks of using this medicine against the
benefits they expect it will have for you.
If you are over 65 years of age you may have an increased chance of getting side effects.
Don't be alarmed by the list of possible side effects.
You may not experience any of them
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following and they worry you:
These are the more common side effects of VALGANCICLOVIR MYLAN and are usually short
Tell your doctor immediately if you notice any of the following:
oral thrush (sore, creamy yellow raised patches in the mouth)
insomnia (inability to sleep)
worsening of your eyesight
These side effects may be serious. You may require urgent medical attention.
Tell your doctor immediately, or go to Accident and Emergency at your nearest hospital,
if you notice any of the following.
swelling of the tongue, lips or throat
any sign of infection such as fever, chills, sore throat or mouth ulcers
unexplained bruising or bleeding
thinking, hearing or seeing things that are not real
Tell your doctor or pharmacist if you notice anything else that is making you feel
unwell, even if it is not on the list.
This is not a complete list of all possible side effects. Others may occur in some
Ask your doctor or pharmacist if you don't understand anything in this list.
After using VALGANCICLOVIR MYLAN
Keep your tablets in the bottle until it is time to take them.
If you take the tablets out of the bottle they may not keep well.
Keep VALGANCICLOVIR MYLAN in a cool dry place where the temperature stays below 25°C.
Do not store it or any other medicine in a bathroom or near a sink. Do not leave
it in the car or on a window sill.
Heat and dampness can destroy some medicines.
Keep VALGANCICLOVIR MYLAN where children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place
to store medicines.
If your doctor tells you to stop taking VALGANCICLOVIR MYLAN, or the tablets have
passed their expiry date, ask your pharmacist what to do with any tablets that are
VALGANCICLOVIR MYLAN comes in 450 mg film-coated tablets, in bottles containing 60
What VALGANCICLOVIR MYLAN looks like
VALGANCICLOVIR MYLAN - valganciclovir 450 mg are pink, biconvex, oval, beveled edge
film-coated tablets with "M" on one side and "V45" on the other side.
Active Ingredients - valganciclovir:
each VALGANCICLOVIR MYLAN tablet contains 450 mg of valganciclovir
Inactive Ingredients -
VALGANCICLOVIR MYLAN film-coated tablets also contain
Iron oxide red
VALGANCICLOVIR MYLAN tablets are lactose and gluten free.
VALGANCICLOVIR MYLAN is supplied in Australia by:
Alphapharm Pty Limited
(ABN 93 002 359 739)
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
Phone: (02) 9298 3999
Australian registration numbers:
VALGANCICLOVIR MYLAN: AUST R 218477
This leaflet was prepared on
15 November 2017.
VALGANCICLOVIR MYLAN_cmi\ Nov17/00